Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting Non-phase study NCT06915909

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial

Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial — Recruiting • Non-phase study • Oncology • NCT06915909.

📅 08 Jul 2026 ⏱ 3 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT06915909
Sponsor
East and North Hertfordshire NHS Trust
Start
2025-04-22
ClinicaliQ Trial Snapshot
  • Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial — Recruiting • Non-phase study • Oncology • NCT06915909.
  • What is being tested: Feasibility of using artificial intelligence to review operative outcomes, specifically pain levels, when comparing two commonly used robotic surgical devices for prostate cancer removal.
  • Patient eligibility overview: The trial involves patients undergoing robotic-assisted laparoscopic prostatectomy (RALP) for prostate cancer treatment, comparing outcomes between the two surgical platforms used in standard clinical practice.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

The 'Robotic Prostatectomy Artificial Intelligence Low Pressure Pain Study Trial' aims to assess the feasibility of being able to review operative outcomes such as pain when comparing two commonly used surgical devices for the removal of prostate cancers. The data collected will inform methodologies for future, larger, multi-center trials investigating pain in patients undergoing prostate cancer surgery. A robotic prostatectomy is a commonly performed surgery used to treat prostate cancer by removing the prostate gland. In order to perform the procedure, the surgeon must 'inflate' (technical term pneumoperitoneum) the patients…

Eligibility Snapshot
  • : * Patient indicated for non-emergent robotic Prostatectomy surgery * Patients (or appropriate legal representatives) able to provide written informed consent to participate in the study * Males, aged 18 to 75 years * Have no significant psychopathology that could limit the subject's ability to understand the procedure, comply with medical, surgical, and/or behavioural recommendations and office visits * Are American Society of Anaesthesiologists (ASA) Class I, II, or III);

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
Wellbeing support demand for cancer patients grows
Oncology · BBC Health · 25 Oct 2026
Key Takeaways for Clinical Practice Cancer patients are reporting increased demand for wellbeing support services, suggesting current provision may not meet patient…
View brief →
Guideline
Trastuzumab deruxtecan for treating HER2-low metastatic or unresectable breast cancer after chemotherapy
Oncology · 07 Oct 2026
Trastuzumab deruxtecan is recommended by NICE as a treatment option for HER2-low metastatic or unresectable breast cancer, making it suitable for patients…
View guideline →
Clinical Brief
‘My cancer spread while I waited months for surgery’: The cost of England’s cancer wait times
Oncology · BBC Health · 10 Sep 2026
England's cancer surgery waiting times have deteriorated despite government initiatives aimed at improving them, with patients experiencing significant delays that may allow…
View brief →
Clinical Brief
Pope pictured for first time since surgery and cancer diagnosis
Oncology · BBC Health · 16 Oct 2026
Pope Francis underwent lung cancer surgery at Gemelli Hospital in Rome; public appearance marks recovery milestone following diagnosis First photographic evidence post-operatively…
View brief →
Guideline
Nirogacestat for treating desmoid tumours
Oncology · 14 Oct 2026
Nirogacestat is recommended as an option for treating desmoid tumours in adults when surgery is not suitable or has failed, enabling consideration…
View guideline →
Guideline
Durvalumab with platinum-based chemotherapy, then with or without olaparib, for untreated advanced or recurrent endometrial cancer
Oncology · 09 Sep 2026
Durvalumab combined with platinum-based chemotherapy is the recommended first-line treatment for untreated advanced or recurrent endometrial cancer, with olaparib addition considered based…
View guideline →